These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Legal implications of preparing and dispensing approved drugs for unlabeled indications. Podell LB Am J Hosp Pharm; 1983 Jan; 40(1):111-3. PubMed ID: 6823981 [TBL] [Abstract][Full Text] [Related]
3. Legal and medical issues in therapeutic interchange: implications for pharmacists, physicians, and P & T committees. Plumeri PA; Crane VS Hosp Formul; 1992 Oct; 27(10):1040-2, 1047-8. PubMed ID: 10121419 [TBL] [Abstract][Full Text] [Related]
4. Drug product selection and the law. Fink JL Contemp Pharm Pract; 1979; 2(3):128-31. PubMed ID: 10242846 [TBL] [Abstract][Full Text] [Related]
5. Legal implications of preparing and dispensing drugs under conditions not in a product's official labeling. Mandl FL; Greenberg RB Am J Hosp Pharm; 1976 Aug; 33(8):814-6. PubMed ID: 949065 [TBL] [Abstract][Full Text] [Related]
6. Guidelines for pharmacists performing product selection. Am Pharm; 1990 Jul; NS30(7):40-1. PubMed ID: 2363394 [No Abstract] [Full Text] [Related]
7. The Ohio Generic Product Selection Law: influence on pharmacy practice. Hunter RH Med Mark Media; 1979 Jul; 14(7):33-6. PubMed ID: 10243269 [No Abstract] [Full Text] [Related]
8. Drug product selection legislation: a comparative analysis. Wetherbee H; Sharpe TR Am J Pharm Sci Support Public Health; 1978; 150(6):171-6. PubMed ID: 576098 [No Abstract] [Full Text] [Related]
9. Package inserts, adverse drug reactions, and the physician's liability. Morrell MX Ration Drug Ther; 1975 Aug; 9(8):1-6. PubMed ID: 1144773 [No Abstract] [Full Text] [Related]
10. The patient package insert and its legal implications. Cook D Leg Med Q; 1980; 4():258-70. PubMed ID: 10258797 [No Abstract] [Full Text] [Related]
12. Impact of drug substitution legislation--implications for continuing education for Michigan pharmacists. Moore WE; Goldberg T; Aldridge GW; Vidis JS; DeVito CA; Dickson WM Contemp Pharm Pract; 1980; 3(2):100-3. PubMed ID: 10246108 [TBL] [Abstract][Full Text] [Related]
13. "Passing off": a current legal issue in marketing of pharmaceuticals. Fink JL; Nelson AA Pharm Manage Comb Am J Pharm; 1979; 151(5):209-10. PubMed ID: 504375 [No Abstract] [Full Text] [Related]
14. Brand substitution the consumer's viewpoint. Nelson AA; Gagnon JP J Am Pharm Assoc; 1975 Jul; 15(7):382-5, 91. PubMed ID: 1133442 [No Abstract] [Full Text] [Related]
15. FTC: our model product selection law relies on the pharmacist's expertise. Holmes PD Pharm Times; 1979 Feb; 45(2):36-9. PubMed ID: 10240271 [No Abstract] [Full Text] [Related]
16. Generic substitution laws--physicians' liability. Trout ME J Leg Med (N Y); 1977 Jul; 5(7):14-6. PubMed ID: 301915 [No Abstract] [Full Text] [Related]
17. Liability of pharmacists for substitution of a generic drug for its brand-name counterpart. Hirsh HL Med Law; 1987; 6(4):293-302. PubMed ID: 3613889 [No Abstract] [Full Text] [Related]
18. Anti-substitution law repeal--pro and con: the case against repeal. Perloff MM Am J Pharm Sci Support Public Health; 1971; 143(1):15-23. PubMed ID: 5162747 [No Abstract] [Full Text] [Related]
19. Forces and direction of drug product selection legislation. Stewart JE Med Mark Media; 1979 Jun; 14(6):34-6, 38-9. PubMed ID: 10242281 [No Abstract] [Full Text] [Related]
20. Drug product selection: the Florida experience revisited. Clouse EH; McCormick WC; Angorn RA; Kimberlin CL; Bradham DD Am J Public Health; 1985 Mar; 75(3):283-4. PubMed ID: 3976956 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]